Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Frontiers in Chemistry|November 21, 2024
New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitorsYaser A Mostafa, Jalil Abdeljalil Assoud, Ahmed Y Desoky, et al.
Bioorganic Chemistry|June 21, 2025
Design, novel one-pot green synthesis, and biological evaluation of pyrazolopyridine-congeners selectively targeting HER2+ breast cancerSamar M Mogheith, Heba Abdelrasheed Allam, Manal Abdel Fattah Ezzat, et al.
Archiv Der Pharmazie|May 6, 2023
Design, synthesis, and docking of novel thiazolidine-2,4-dione multitarget scaffold as new approach for cancer treatmentNoura S Hanafy, Nada A A M Aziz, Sanadelaslam S A El-Hddad, et al.
Bioorganic Chemistry|August 13, 2024
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agentsBassem H Naguib, Heba A Elsebaie, Mohamed S Nafie, et al.
Drug Development Research|February 13, 2024
2-Thioxo-3,4-dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFRT790M and VEGFR-2 inhibitors: Design, synthesis, docking, and anticancer evaluationsMohamed S A El-Gaby, Mohamed A M Abdel Reheim, Zuhir S M Akrim, et al.
RSC Advances|December 6, 2023
Five and six membered heterocyclic rings endowed with azobenzene as dual EGFRT790M and VEGFR-2 inhibitors: design, synthesis, in silico ADMET profile, molecular docking, dynamic simulation and anticancer evaluationsKurls E Anwer, Sanadelaslam S A El-Hddad, Nour E A Abd El-Sattar, et al.
RSC Advances|March 8, 2024
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular dockingAhmed K B Aljohani, Khaled El-Adl, Basmah Almohaywi, et al.
Pageof 3